BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17179690)

  • 1. Association of the GSTP1 and NQO1 polymorphisms and head and neck squamous cell carcinoma risk.
    Cho CG; Lee SK; Nam SY; Lee MS; Lee SW; Choi EK; Park HJ; Kim SY
    J Korean Med Sci; 2006 Dec; 21(6):1075-9. PubMed ID: 17179690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
    Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D
    Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism in cytochrome P450 2A6 and glutathione S-transferase P1 modifies head and neck cancer risk and treatment outcome.
    Ruwali M; Pant MC; Shah PP; Mishra BN; Parmar D
    Mutat Res; 2009 Oct; 669(1-2):36-41. PubMed ID: 19406142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of NQO1, GSTP1, and MnSOD genetic polymorphisms on lung cancer risk in Taiwan.
    Lin P; Hsueh YM; Ko JL; Liang YF; Tsai KJ; Chen CY
    Lung Cancer; 2003 May; 40(2):123-9. PubMed ID: 12711112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic polymorphisms of MPO, NQO1, GSTP1, UGT1A6 associated with susceptibility of chronic benzene poisoning].
    Sun P; Zhang Z; Wan J; Shao M
    Wei Sheng Yan Jiu; 2007 Jan; 36(1):11-5. PubMed ID: 17424838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms of MPO, GSTT1, GSTM1, GSTP1, EPHX1 and NQO1 as risk factors of early-onset lung cancer.
    Timofeeva M; Kropp S; Sauter W; Beckmann L; Rosenberger A; Illig T; Jäger B; Mittelstrass K; Dienemann H; ; Bartsch H; Bickeböller H; Chang-Claude J; Risch A; Wichmann HE
    Int J Cancer; 2010 Oct; 127(7):1547-61. PubMed ID: 20091863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
    Werbrouck J; De Ruyck K; Duprez F; Van Eijkeren M; Rietzschel E; Bekaert S; Vral A; De Neve W; Thierens H
    Mutat Res; 2008 Oct; 656(1-2):74-81. PubMed ID: 18768166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined GSTP1 and NQO1 germline polymorphisms in the susceptibility to Multiple Sclerosis.
    Alexoudi A; Zachaki S; Stavropoulou C; Chatzi I; Koumbi D; Stavropoulou K; Kollia P; Karageorgiou CE; Sambani C
    Int J Neurosci; 2015 Jan; 125(1):32-7. PubMed ID: 24588223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of the glutathione S-transferase P1 gene and head and neck cancer susceptibility.
    Oude Ophuis MB; Roelofs HM; van den Brandt PA; Peters WH; Manni JJ
    Head Neck; 2003 Jan; 25(1):37-43. PubMed ID: 12478542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue.
    Ko Y; Abel J; Harth V; Bröde P; Antony C; Donat S; Fischer HP; Ortiz-Pallardo ME; Thier R; Sachinidis A; Vetter H; Bolt HM; Herberhold C; Brüning T
    Cancer Res; 2001 Jun; 61(11):4398-404. PubMed ID: 11389067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between glutathione S-transferase P1 genotype and plasma level in head and neck cancer.
    Kelders WP; Oude Ophuis MB; Roelofs HM; Peters WH; Manni JJ
    Laryngoscope; 2002 Mar; 112(3):462-6. PubMed ID: 12148855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association of NQO1 and GSTP1 polymorphisms with multiple myeloma risk.
    Maggini V; Buda G; Galimberti S; Martino A; Orciuolo E; Morabito F; Bono R; Barale R; Petrini M; Rossi AM
    Leuk Res; 2008 Jun; 32(6):988-90. PubMed ID: 18061666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
    Schneider J; Bernges U; Philipp M; Woitowitz HJ
    Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutathione S-transferase T1 null polymorphism and the risk for head and neck cancer.
    Oude Ophuis MB; Manni JJ; Peters WH
    Acta Otolaryngol; 2006 Mar; 126(3):311-7. PubMed ID: 16618661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
    Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
    Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP1A2*1C, CYP2E1*5B, and GSTM1 polymorphisms are predictors of risk and poor outcome in head and neck squamous cell carcinoma patients.
    Olivieri EH; da Silva SD; Mendonça FF; Urata YN; Vidal DO; Faria Mde A; Nishimoto IN; Rainho CA; Kowalski LP; Rogatto SR
    Oral Oncol; 2009 Sep; 45(9):e73-9. PubMed ID: 19442564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GSTM1, GSTP1, and NQO1 polymorphisms and susceptibility to atopy and airway hyperresponsiveness among South African schoolchildren.
    Reddy P; Naidoo RN; Robins TG; Mentz G; London SJ; Li H; Naidoo R
    Lung; 2010 Oct; 188(5):409-14. PubMed ID: 20526719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphisms in NQO1 and the clinical course of urinary bladder neoplasms.
    Sanyal S; Ryk C; De Verdier PJ; Steineck G; Larsson P; Onelöv E; Hemminki K; Kumar R
    Scand J Urol Nephrol; 2007; 41(3):182-90. PubMed ID: 17469025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of CYP1A1, GSTM1, GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish population.
    Alexandrie AK; Nyberg F; Warholm M; Rannug A
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):908-14. PubMed ID: 15184245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible Implication of GSTP1 and NQO1 Polymorphisms on Natalizumab Response in Multiple Sclerosis.
    Alexoudi A; Zachaki S; Stavropoulou C; Gavrili S; Spiliopoulou C; Papadodima S; Karageorgiou CE; Sambani C
    Ann Clin Lab Sci; 2016 Dec; 46(6):586-591. PubMed ID: 27993870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.